Veterinary Medicines

Versiguard Rabies, Suspension for injection

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Download as PDF

Product identification

Medicine name:
Vesigyard Rabies suspension injectable
Versiguard Rabies, Suspension for injection
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
  • Cat
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Horse
  • Ferret
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Ferret
  • Subcutaneous use
    • Dog
    • Cat
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Glass Vial 1 x 1.0 Dose
  • Glass Vial 10 x 10.0 Dose
  • Glass Vial 10 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/06/10/0890
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0100/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."